It wasn’t too long ago that selling marijuana could get you a one-way ticket to the big house. But now, as more states move forward with legalizing marijuana, that trip to the big house can turn into a trip to the bank.
The legalization of marijuana in the US has lit a spark with investors who are turning their focus to the small — but rapidly expanding — medical marijuana industry.
“Everybody is running toward this as the next entrepreneurial wave — the green rush,” Robert Frichtel, CEO of Advanced Cannabis Solutions, told Bloomberg Businessweek in a January 2014 interview.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

A long-term play?

And indeed, the sector has already seen significant growth. A report by leading marijuana industry and investment research firm ArcView shows that sales of legal cannabis climbed 17 percent, to $5.4 billion, in 2015 and look set to grow an even more significant 25 percent in 2016. What’s more, sales may grow to a whopping $21.8 billion in 2020.
Those numbers may sound impressive, but many market watchers are calling marijuana a long-term investment. That’s because as with any new opportunity, there is a fair amount of risk in investing in marijuana. Those risks and challenges include the overarching decriminalization of marijuana at the federal level in the US, among other regulatory threats.
Penny stocks are also a risk — in the past, the Financial Regulatory Authority has even warned investors to be on the lookout for marijuana stock scams.
Overall, however, it seems that despite any concerns market watchers might have, the cannabis industry isn’t going to go up in smoke any time soon. “Business is very good,” Frichtel told The Globe and Mail. “We are in the early stages of what’s going to be a very large industry over time.”


 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

And indeed, “over time” seems to be the key statement. Alan Brochstein, a financial analyst in Houston who runs 420investor.com, told the Globe, “[e]verybody wants to get rich real quick, and that’s not the best way to look at these companies … You need to think long term.”
“It’s a multibillion-dollar industry,” Brochstein added. “These companies that people can buy right now are just a teeny, tiny fraction of the industry. They get a lot of focus because people can invest in them, but the reality is that better companies are going to be what you want to invest in. It’s just a question of when they come.”
Wall St. Cheat Sheet has echoed the sentiment that investors should steer clear of marijuana stocks — at least for the moment — as prices are especially elevated. Instead, the publication suggests that those investors who can ignore the high of the speculative investments look for companies that are “poised to capitalize on the evolution of the market.”

Investor takeaway

But what companies are those exactly? There are many choices, and often a good place to start is by looking at expert recommendations. The Investing News Network recently interviewed Derwin Wallace of Cannabis Investor Webcast for his thoughts on North American cannabis stocks, and more stock picks can be found in our recent cannabis investing outlook.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

 
Securities Disclosure: I, Vivien Diniz, hold no direct investment interest in any of the companies mentioned in this article.

Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States today announced the appointment of Marcum LLP (“Marcum”) as its independent registered public accounting firm, effective July 5, 2021 . Marcum was appointed following the resignation of MNP LLP (“MNP”) as the Company’s independent registered public accounting firm effective July 5, 2021 .

“We would like to thank MNP for their guidance and expertise over the past two years and we look forward to working with Marcum as the Company’s new independent registered public accounting firm,” stated Chief Financial Officer, Alex D’Amico.

Keep reading... Show less

Cannabis-infused beverages are not a new product concept, but this summer Canadian drink makers hope consumers will discover them for the first time.

Recreational cannabis beverages have beguiled Canadian producers through different avenues, and many continue to make investments. The promise of these drinks lies in the potential of a more welcoming option for new consumers who may be out of their depth with rolled-up dried flower.

Keep reading... Show less

In the news release, BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years, issued 07-Jul-2021 by BioHarvest Sciences Inc. over PR Newswire, we are advised by the company that an incorrect version of the release was issued inadvertently. The complete, corrected release follows:

BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years

Keep reading... Show less

Trulieve is the first medical cannabis operator to start planting in the state

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today that it commenced operations in West Virginia . The Company has begun cultivation at their 100,000 square foot size facility in Huntington, West Virginia .

Keep reading... Show less

– The Company demonstrates the efficiency and reliability of its BioFarming technology by reducing production cycle time for Cannabis from 14-23 weeks to 3-4 weeks.

– The Company’s BioFarming technology will allow the Company to harvest 13-17 cycles per year versus 2-4 cycles per year for conventional Cannabis agriculture.

Keep reading... Show less